Patrick John Finn - 28 Oct 2025 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
President and COO
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn
Issuer symbol
TWST
Transactions as of
28 Oct 2025
Net transactions value
$0
Form type
4
Filing time
30 Oct 2025, 16:05:16 UTC
Previous filing
27 Oct 2025
Next filing
03 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Finn Patrick John President and COO C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO /s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn 30 Oct 2025 0001755970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +79,785 +39% $0.000000 286,280 28 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement.